Compare HWBK & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HWBK | EMBC |
|---|---|---|
| Founded | 1865 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.0M | 207.1M |
| IPO Year | 1996 | 2021 |
| Metric | HWBK | EMBC |
|---|---|---|
| Price | $39.43 | $3.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 12.6K | ★ 2.4M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | 2.49% | ★ 6.88% |
| EPS Growth | ★ 31.42 | 20.90 |
| EPS | ★ 0.83 | 0.67 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.17 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $48.18 | ★ $5.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.10 | $2.77 |
| 52 Week High | $40.36 | $15.55 |
| Indicator | HWBK | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 55.17 | 44.91 |
| Support Level | $33.50 | $3.01 |
| Resistance Level | N/A | $3.48 |
| Average True Range (ATR) | 1.56 | 0.18 |
| MACD | 0.06 | 0.13 |
| Stochastic Oscillator | 68.61 | 76.53 |
Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, and checking, savings and money market accounts. It has two segments, banking and wealth management, with the banking segment earning the majority of its revenue and conducting general banking business, offering checking and savings accounts, internet banking, debit cards, certificates of deposit, brokerage services and others. Its primary source of revenue is net interest income derived from lending and deposit taking activities.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.